杏芎氯化钠注射液治疗急性脑梗塞32例临床观察Word文档下载推荐.docx
《杏芎氯化钠注射液治疗急性脑梗塞32例临床观察Word文档下载推荐.docx》由会员分享,可在线阅读,更多相关《杏芎氯化钠注射液治疗急性脑梗塞32例临床观察Word文档下载推荐.docx(3页珍藏版)》请在冰豆网上搜索。
方法将62例急性脑梗塞患者随机分成治疗组和对照组。
两组常规治疗方法相同。
治疗组给予杏芎氯化钠注射液1次/d,静脉滴注;
对照组加丹奥注射液、克林澳注射液2次/d,静脉滴注,脑细胞活化剂特安欣(肌氨肽苷)注射液1次/d,静脉滴注,2周后观察疗效。
结果治疗组与对照组的总有效率分别为%和%(),显效率分别为%、%(),均无显着性差异。
治疗组在改善神经功能缺损方面明显好于对照组()。
结论杏芎氯化钠注射液治疗急性脑梗塞具有多种治疗作用,用药简便、疗效确切,而且在改善神经功能缺损方面作用较好,值得临床推广应用。
【关键词】杏芎氯化钠注射液;
急性脑梗塞;
临床疗效
Abstract:
ObjectiveToobservethetherapeuticeffectofFloiumGinkgoextractandTertramEthypyrazinesodiumchlorideinjectiononacutecerebraltwocasesofpatientswithacutecerebralinfarctionweredividedintotwogroupsatrandom,treatmentgroup(32cases)andcontrolgroup(30cases).Bothofthegroupsweretreatedwiththesameordinary casesofthetreatmentgroupweregivenFloiumGinkgoextractandTertramEthypyrazinesodiumchlorideinjectionqd,ivgtt.ThecasesofthecontrolgroupweregivensodiumOzagrel,CinepazideMaleateinjection,bid,ivgtt.andMuscularAminoAcidsandPeptidesandNucleosidesInjectiontoobservetheefficacy.Thetreatmentcoursewas2 wasnosignificantdifferencebetweentwogroups.Thetotaleffectiverateinthetreatmentgroupandthecontrolgroupwas%and%respectively()andtheexcellenteffectiveratewas%and%respectively().Theneurologicalfunctiondefectscoringinthetreatmentgroupwassignificantlybetterthanthatofinthecontrolgroup().ConclusionBecauseFloiumGinkgoextractandTertramEthypyrazinesodiumchlorideinjectioniseasilyusedandhasacocktailpositiveeffectonmanykindsoftreatmentactionandimprovementofneurologicalfunctiondefectinclinic,itisworthbeingpopularizedandusedclinically.
KeywordsFloiumGinkgoextractandTertramEthypyrazinesodiumchlorideinjection,Acutecerebralinfarction,Curativeeffect
Cerebralinfarctionisalsocalledischemiabrainstroke,acommonandfrequentcerebrovasculardiseaseinclinic,itisthethirdleadingcauseofdeathinallkindsofdiseaseinmiddle-agedpopulationinclinicwithhighmorbiditymortalityanddisability.Inrecentyearsacutecerebralinfarctionisincreasingtendtoyoung[1],atpresentnosinglewesternagentcancureiteffectively,butFloiumGinkgoextractandTertramEthypyrazinesodiumchlorideinjectioncandoit.Itwillexpandanewtrainofthoughtandopenwidelyfieldofvisionbecauseitcontainsavarietyofmoleculeswithpotentbiologicalactivitiesandacocktailtherapeuticmethodtocureacutecerebralinfarction,butthedrughasn‘tbeenusedforalongperiodoftime,wewillobserveitsefficacyinclinicinordertofurtherinvestigatetherapeuticeffect.
1ClinicalMaterial
Allthecasesweredividedrandomlyintotreatmentgroup(32cases)andcontrolgroup(30cases)from62consecutiveacutecerebralinfarctionpatientsadmittedtoourhospital.Diagnosisofacutecerebralinfarctionforeachcasewasmadeaccordingtostandardofcerebralinfarctiondiagnosisandbraincomputedtomography(CT)and/ormagneticresonanceimages(MRI)wereusedtoconfirmthediagnosis.Patientswithcerebralhemorrhage,liverdisfunction,renaldisfunction,cardiovasculardiseasesandhematologicaldiseaseswereexcluded.
Therewasnosignificantdifferencebetweentwogroupsinages,sexes,symptoms,scoresofneurologicalfunctiondefectandordinarymethodbeforethepatientsadmittedtohospitalbystatisticalanalysis.
StandardofdiagnosisDiagnosisofacutecerebralinfarctionwasmadeaccordingtotheChineseneurologicalacademyaboutessentialsofdiagnosisoneachkindofcerebrovasculardisease[2].Braincomputedtomography(CT)and/ormagneticresonanceimages(MRI)wereusedtoconfirmthediagnosis.
Tab1Comparisonofgeneralconditionsinthetwogroups
Clinicalsymptomsofacutecerebralinfarctionoftensuddenlytroublestandingorwalking,speakingorunderstanding,seeingwithoneorbotheyesanddizziness,lossofbalanceorcoordination,numbnessoftheface,armorlegweakness,especiallyononesideofthebody,severeheadacheswithnoknowncause,brieflossofconsciousnessoraperiodofdecreasedconsciousness(fainting,confusion,convulsionsorevencoma).
2TherapeuticMethods
Theordinarymethod:
thecaseswithhypertensionwasgivenanti-hypertension[3],withhyperglycemiagivenanti-hyperglycemia,withhighlipidgivenlowingbloodlipid,hydrocephalus,andoxygenation,radiotherapyaccordingtotheconcreteconditionsofacutecerebralinfarction.
ThetreatmentgroupwasgivenFloiumGinkgoextractandTertramEthypyrazinesodiumchlorideinjection100~250ml,qd,iv controlgroupwasgivensodiumOzagrel160mg,CinepazideMaleate160mginjectionaddto%NaCl,bid,ivgttandMuscularAminoAcidsandPeptidesandNucleosides10mlInjectionqd,ivgtt.Thetreatmentcoursewas2weeks.
Statisticalanalysesweremadeusingthetargetofneurologicalfunctiondefectscorningandclinicalsympto